Affiliation:
1. Prince of Songkla University
Abstract
Pseudolatex is colloidal dispersion containing spherical solid or semisolid particles and can be prepared from any existing thermoplastic water-insoluble polymers. It is useful for drug encapsulation and controlled drug release. In this study, pseudolatex base was prepared from STR 5L block rubber. The various parameters such as speed and time of homogenization, type and concentration of surfactants, amount of mineral oil, and type of drug loading were studied to prepare the stable pseudolatex. These preparations were evaluated in particle size, pH, viscosity, emulsion stability, drug encapsulation, and in vitro drug release. It was found that the most stable formulation contained 3.5% block rubber, 0.2% methyl cellulose, 6% mineral oil, 4% dibutyl phthalate, 2% sodium lauryl sulfate, and 2% Uniphen P-23 using the speed and time of homogenizer as 20000 rpm and 20 minutes, respectively. Furthermore, the pseudolatex bases reduced the protein impurity form 0.5516% to 0.2108% in formulation with mineral oil and to 0.1781% in formulation without mineral oil, that could decrease contact allergy caused by the protein allergens. Dichloromethane residues in pseudolatex bases were 22.05 mg/L and 7.85 mg/L in formulations with and without mineral oil, respectively, that were satisfied from USP recommendation value of lower than 600 mg/L. Propranolol HCl, lidocaine HCl, and indomethacin could be loaded into pseudolatex only in the concentration of 1%. However, lidocaine base in the concentration of 1-5% could be loaded into pseudolatex which had the similar physical properties and stability to pseudolatex base. The in vitro drug release from pseudolatexs provided the controlled drug release for more than 24 hr.
Publisher
Trans Tech Publications, Ltd.
Reference7 articles.
1. C. Amnuaikit, Formulation development of diltiazem hydrochloride transdermal drug delivery system utilizing pseudolatex base, M.S. Thesis, Faculty of Pharmaceutical Sciences, Chulalongkorn University: Bangkok, Thailand, (2000), 152 p.
2. M.E. Morales, M.A. Ruiz, G. López, and V. Gallardo, Development of oral suspensions of microparticles of ethylcellulose with tramadol. Drug Dev. Ind. Pharm. 36(8) (2010) 885-892.
3. L. Panigrahi, S. Pattnaik, and S.K. Ghosal, The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins. AAPS PharmSciTech. 6(2) (2005).
4. D. Quintanar-Guerrero, E. Allémann, H. Fessi, and E. Doelker, Pseudolatex preparation using a novel emulsion–diffusion process involving direct displacement of partially water-miscible solvents by distillation. Int. J. Pharm. 188(2) (1999).
5. S.V. Sastry, W. Wilber, I.K. Reddy, and M.A. Khan, Aqueous-based polymeric dispersion: preparation and characterization of cellulose acetate pseudolatex. Int. J. Pharm. 165(2) (1998) 175-189.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献